Study for serum total cholesterol-lowering action of egg white protein containing beverage

Not Applicable

Completed

• Conditions: ormo- and mildly hypercholesterolemic subjects

• Registration Number: JPRN-jRCT1090220279
• Lead Sponsor: Kewpie Corporation

Brief Summary

E may be effective in helping to prevent arteriosclerotic diseases.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2006-11-09
• Study Start: 2017-03-13
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 88

Inclusion Criteria

(1) Japanese males with mild hypercholesterolemia of at least 20 years and not more than 65 years of age, (2) not undergoing treatment for hyperlipidemia, (3) not undergoing treatment for diabetes, (4) had no subjective symptoms of gout, (5) capable of filling out necessary forms such as self-diagnosis forms, and (6) capable of visiting a designated institution as scheduled.

Exclusion Criteria

(1) those who were taking drugs considered to potentially affect test results (e.g., anti-hyperlipidemic agents, anti-diabetic agents, oral corticosteroid formulations, and antihypertensive agents), (2) were regularly consuming foods for specified health uses considered to potentially affect test results, (3) were excessively consuming alcohol, (4) suspected to develop allergic reactions (particularly those allergic to egg and milk), (5) those who were participating in other clinical studies, (6) had a history of serious liver damage, kidney damage, or myocardial infarction, (7) had a history of or currently had hepatitis, and (8) had serious anemia. The candidates who fulfilled the abovementioned criteria then underwent a screening survey.

Study & Design

• Study Type: Interventional
• Study Design: Not specified